Tatsuya Ihara Selected Research

Cystitis

1/2016

AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuya Ihara Research Topics

Disease

6	Nocturia 11/2023 - 01/2019
3	Neoplasms (Cancer) 09/2022 - 12/2021
3	Overactive Urinary Bladder (Overactive Bladder) 03/2022 - 08/2018
2	Lower Urinary Tract Symptoms 01/2018 - 01/2018
1	Chronobiology Disorders (Circadian Rhythm Disorder) 11/2023
1	Prostatic Neoplasms (Prostate Cancer) 09/2022
1	Hyperaldosteronism (Conn Syndrome) 06/2022
1	Cushing Syndrome 06/2022
1	Obesity 06/2022
1	Urge Urinary Incontinence (Urge Incontinence) 03/2022
1	Pulmonary Atelectasis 12/2021
1	Mediastinal Emphysema (Pneumomediastinum) 12/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2021
1	Carcinogenesis 01/2019
1	Small Cell Carcinoma 07/2017
1	Hyponatremia 07/2017
1	Inappropriate ADH Syndrome (SIADH) 07/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2017
1	Infections 02/2017
1	Granuloma 02/2017
1	Epididymitis 02/2017
1	Inflammation (Inflammations) 01/2016
1	Cystitis 01/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	palmidrolIBA 11/2023 - 10/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 02/2020
2	AcidsIBA 01/2022 - 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2023
1	Nerve Growth Factor (NGF)IBA 11/2023
1	dimemorfan (AT 17)IBA 10/2023
1	pembrolizumabIBA 09/2022
1	mirabegronIBA 03/2022
1	LipidsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 07/2021
1	Serotonin (5 Hydroxytryptamine)IBA 10/2020
1	hydracrylic acidIBA 10/2020
1	Bile Acids and Salts (Bile Acids)IBA 02/2020
1	4- hydroxy- 5,7,10,13,16,19- docosahexaenoic acidIBA 10/2019
1	Arachidonic Acid (Vitamin F)IBA 10/2019
1	13-hydroxy-9,11-octadecadienoic acidIBA 10/2019
1	anandamide (arachidonylethanolamide)IBA 10/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Eicosapentaenoic AcidIBA 10/2019
1	9-hydroxyoctadecadienoic acidIBA 10/2019
1	EndocannabinoidsIBA 10/2019
1	lauric acid (dodecanoic acid)IBA 01/2019
1	imidazolelactic acidIBA 01/2019
1	thiazolidine-4-carboxylic acidIBA 01/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2019
1	CitrullineIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Inosine Monophosphate (IMP)IBA 01/2018
1	AsparagineIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	ConnexinsIBA 01/2018
1	Vasopressins (Vasopressin)IBA 07/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Connexin 43 (Connexin43)IBA 01/2016
1	AICA ribonucleotide (ZMP)IBA 01/2016

Therapy/Procedure

3	Therapeutics 09/2022 - 02/2017
2	Operative Time 06/2022 - 12/2021
1	Adrenalectomy 06/2022
1	Warm Ischemia 12/2021
1	Nephrectomy 12/2021
1	Radiotherapy 07/2017